Dallan Murray is Chief Customer Officer of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 29,926 shares of SRPT, which is worth approximately $575,476. The most recent transaction as insider was on Mar 10, 2025, when has been sold 3,733 shares (Common Stock) at a price of $100.13 per share, resulting in proceeds of $373,785. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.9K
0% 3M change
35.89% 12M change
Total Value Held $575,476

Dallan Murray Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 10 2025
SELL
Payment of exercise price or tax liability
$373,785 $100.13 p/Share
3,733 Reduced 11.09%
29,926 Common Stock
Mar 10 2025
BUY
Grant, award, or other acquisition
-
8,276 Added 17.81%
38,202 Common Stock
Mar 07 2025
SELL
Payment of exercise price or tax liability
$950,099 $103.7 p/Share
9,162 Reduced 24.55%
28,159 Common Stock
Mar 07 2025
BUY
Exercise of conversion of derivative security
-
5,500 Added 14.05%
33,659 Common Stock
Mar 06 2025
BUY
Exercise of conversion of derivative security
-
17,500 Added 31.92%
37,321 Common Stock
Mar 04 2025
SELL
Payment of exercise price or tax liability
$170,757 $101.34 p/Share
1,685 Reduced 7.84%
19,821 Common Stock
Mar 03 2025
SELL
Payment of exercise price or tax liability
$73,780 $103.77 p/Share
711 Reduced 3.2%
21,506 Common Stock
Jun 24 2024
SELL
Payment of exercise price or tax liability
$387,233 $164.64 p/Share
2,352 Reduced 9.65%
22,023 Common Stock
Jun 21 2024
BUY
Exercise of conversion of derivative security
-
6,250 Added 20.41%
24,375 Common Stock
May 02 2024
SELL
Open market or private sale
$508,900 $140.0 p/Share
3,635 Reduced 16.7%
18,125 Common Stock
DM

Dallan Murray

Chief Customer Officer
Cambridge, MA

Track Institutional and Insider Activities on SRPT

Follow Sarepta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRPT shares.

Notify only if

Insider Trading

Get notified when an Sarepta Therapeutics, Inc. insider buys or sells SRPT shares.

Notify only if

News

Receive news related to Sarepta Therapeutics, Inc.

Track Activities on SRPT